Inventor · disambiguated record
Conrad Padraig Quinn
Also filed as: QUINN CONRAD · QUINN CONRAD P · QUINN CONRAD PADRAIG
24 granted patents·12 pending applications·1,052 citations·filing 1996–2017
96Inventor score
Files withHEALTH PROT AGENCY6SYNTAXIN LTD6MICROBIOLOGICAL RES AUTHORITY4QUINN CONRAD PADRAIG3BOYER ANNE E2
Top patents by PatentIndex Score
36 records- 0198US7192596B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2002·Granted Mar 20, 2007·160 cites·42 claims
- 0298US6461617B1Recombinant toxin fragmentsMICROBIOLOGICAL RES AUTHORITY·Filed 1999·Granted Oct 8, 2002·229 cites·10 claims
- 0397US6632440B1Methods and compounds for the treatment of mucus hypersecretionHEALTH PROT AGENCY·Filed 1999·Granted Oct 14, 2003·263 cites·19 claims
- 0496US7727538B2Methods and compounds for the treatment of mucus hypersecretionSYNTAXIN LTD·Filed 2006·Granted Jun 1, 2010·22 cites·21 claims
- 0594US7897158B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2007·Granted Mar 1, 2011·11 cites·17 claims
- 0694US5962637AToxin assayMICROBIOLOGICAL RES AUTHORITY·Filed 1996·Granted Oct 5, 1999·119 cites·15 claims
- 0793US6337386B1Toxin AssayMICROBIOLOGICAL RES AUTHORITY·Filed 2000·Granted Jan 8, 2002·58 cites·16 claims
- 0891US7674470B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2005·Granted Mar 9, 2010·13 cites·30 claims
- 0990US8012479B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2009·Granted Sep 6, 2011·4 cites·16 claims
- 1089US8012491B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 6, 2011·6 cites·10 claims
- 1188US7208466B1Use of a lectin or conjugates for modulation of c-fibre activityHEALTH PROT AGENCY·Filed 2000·Granted Apr 24, 2007·31 cites·4 claims
- 1287US8017134B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 13, 2011·5 cites·12 claims
- 1387US6043042AAntibody for a toxin assay, and method of obtaining sameMICROBIOLOGICAL RES AUTHORITY·Filed 1998·Granted Mar 28, 2000·110 cites·13 claims
- 1485US8454976B2Recombinant toxin fragmentsSHONE CLIFFORD CHARLES·Filed 2008·Granted Jun 4, 2013·5 cites·18 claims
- 1584US8790897B2Treatment of mucus hypersecretionQUINN CONRAD PADRAIG·Filed 2007·Granted Jul 29, 2014·6 cites·14 claims
- 1676US8852603B2Inhibition of secretion from non-neuronal cellsFOSTER KEITH ALAN·Filed 2012·Granted Oct 7, 2014·3 cites·6 claims
- 1769US2007248626A1Recombinant toxin fragmentsIPSEN LTD·Filed 2006·Application pending·0 cites
- 1866US2008152667A1Methods and compounds for the treatment of mucus hypersecretionQUINN CONRAD PADRAIG·Filed 2007·Application pending·0 cites
- 1964US9046520B2Serologic correlates of protection against Bacillis anthracis infectionSEMENOVA VERA A·Filed 2011·Granted Jun 2, 2015·1 cites·8 claims
- 2064US2004071736A1Methods and compounds for the treatment of mucus hypersecretionHEALTH PROT AGENCY·Filed 2003·Application pending·0 cites
- 2163US8420607B2Anthrax carbohydrates, synthesis and uses thereofCARLSON RUSSELL W·Filed 2008·Granted Apr 16, 2013·3 cites·14 claims
- 2262US8663926B2Detection of anthrax pathogenicity factorsBOYER ANNE E·Filed 2007·Granted Mar 4, 2014·2 cites·20 claims
- 2360US9102742B2Serologic correlates of protection against Bacillus anthracis infectionCENTERS DISEASE CONTROL & PREVENTION·Filed 2013·Granted Aug 11, 2015·1 cites·18 claims
- 2459US9782465B2Serologic correlates of protection against Bacillus anthracis infectionUS HEALTH·Filed 2017·Granted Oct 10, 2017·0 cites·10 claims
- 2558US2014348828A1Inhibition of secretion from non-neuronal cellsSYNTAXIN LTD·Filed 2014·Application pending·0 cites
- 2657US2009280066A1Methods and compounds for the treatment of mucus hypersecretionQUINN CONRAD PADRAIG·Filed 2007·Application pending·0 cites
- 2756US2006216283A1Inhibition of secretion from non-neuronal cellsFOSTER KEITH A·Filed 2006·Application pending·0 cites
- 2856US2008038274A1Inhibition of secretion from non-neuronal cellsFOSTER KEITH A·Filed 2007·Application pending·0 cites
- 2951US9610338B2Serologic correlates of protection against bacillus anthracis infectionTHE US SECRETARY DPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Apr 4, 2017·0 cites·8 claims
- 3051US2011152174A1Inhibition of secretion from non-neuronal cellsSYNTAXIN LTD·Filed 2011·Application pending·0 cites
- 3150US2003180289A1Inhibition of secretion from non-neuronal cellsFiled 2002·Application pending·0 cites
- 3247US9310366B2Anthrax carbohydrates, synthesis and uses thereofUNIV GEORGIA·Filed 2013·Granted Apr 12, 2016·0 cites·23 claims
- 3345US2008070278A1Novel agent for controlling cell activityNORTH JOHN R·Filed 2007·Application pending·0 cites
- 3442US9845349B2Regulating Bacillus anthracis lethal factor activity via an activating epitope regionUS HEALTH·Filed 2015·Granted Dec 19, 2017·0 cites·5 claims
- 3542US2016039874A1Regulating bacillus anthracis lethal factor activity via an activating epitope regionUS OF AMERICA AS REPRESENTED BY TH SECRETART DEPT OF HEALTH AND HUMAN SERVICE·Filed 2013·Application pending·0 cites
- 3635US2013210031A1Detection of adenylate cyclaseBOYER ANNE E·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Conrad Padraig Quinn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →